Literature DB >> 12633952

Title comparison of primary and secondary spinal epidural abscesses: a retrospective analysis of 29 cases.

ShahNaz H Khan1, M Shazam Hussain, Robert W Griebel, Suzanne Hattingh.   

Abstract

BACKGROUND: Spinal epidural abscesses (SEA) are uncommon. In certain regions their incidence is rising. Vague initial presentation may result in delayed diagnosis. Familiarity with SEA is imperative because if not treated expeditiously, they can have devastating neurologic sequelae.
METHODS: A retrospective analysis using analysis of variance (ANOVA) was performed on patients diagnosed with SEA between 1980 through 2000. The patients were assigned to one of the two defined groups: primary (PSEA) consisted of SEA alone; secondary (SSEA) included SEAs with vertebral osteomyelitis. Both groups were compared for factors including survival, age, diagnostic accuracy, etiology, hospitalization, management, and outcome.
RESULTS: Twenty-nine cases were identified. Four (23.7%) were PSEAs and 25 (86.2%) were SSEAs. Mean age (52.7 vs. 53.2 years) and mean duration of hospitalization (39.2 vs. 38.6 days) were comparable in both groups (p = 0.9). The admitting diagnosis was correct in 75% of PSEA and 20% of SSEA cases (p = 0.1). Staphylococcus aureus was present in 75% and 68%, respectively. In SSEA cases, 24% (n = 6) of the infections were consequent to spinal surgery. PSEA did not show a predilection for any level. Most (56%) cases of SSEA occurred at the lumbar levels. The entire PSEA group and 58.3% of the SSEA group underwent surgery (p = 0.06), 75% versus 40.9% had a good outcome for PSEA and SSEA, respectively.
CONCLUSIONS: PSEAs are very rare. Both groups have similar characteristics. Staphylococci remain the predominant etiologic agent. PSEAs are treated by surgery; SSEAs are managed surgically or conservatively.

Entities:  

Mesh:

Year:  2003        PMID: 12633952     DOI: 10.1016/s0090-3019(02)00925-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  12 in total

1.  [Cervical epidural abscess following lumbar epidural steroid injections].

Authors:  Friedrich Götz; Heinrich Lanfermann; Hartmut Becker
Journal:  Klin Neuroradiol       Date:  2009-08-23

2.  Clinical outcomes of spinal epidural abscess.

Authors:  HyunJin Ma; Insoo Kim
Journal:  Korean J Spine       Date:  2012-03-31

Review 3.  Musculoskeletal Infections in the Emergency Department.

Authors:  Daniel C Kolinsky; Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

4.  Late Prevertebral and Spinal Abscess following Chemoradiation for Laryngeal Squamous Cell Carcinoma.

Authors:  Jawad Hindy; Ilan Shelef; Yuval Slovik; Ben-Zion Joshua
Journal:  Case Rep Otolaryngol       Date:  2014-02-19

Review 5.  Upper Cervical Epidural Abscess in Clinical Practice: Diagnosis and Management.

Authors:  Khalid Al-Hourani; Rami Al-Aref; Addisu Mesfin
Journal:  Global Spine J       Date:  2015-10-13

6.  Upper Cervical Epidural Abscess in a Patient With Parkinson Disease: A Case Report and Review.

Authors:  Khalid Al-Hourani; Chelsea Frost; Addisu Mesfin
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-12

7.  Cervical epidural abscess in haemodialysis patients by catheter related infection: report of two cases.

Authors:  Ali Riza Gezici; Rüçhan Ergün
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

8.  Metastatic Spreading of Community Acquired Staphylococcus aureus Bacteraemia.

Authors:  Giovanna Fabio; Maria Carrabba; Luca Mellace; Cinzia Hu; Diego Spagnoli; Maria Domenica Cappellini
Journal:  Case Rep Infect Dis       Date:  2011-07-03

9.  Rapidly Progressive Spontaneous Spinal Epidural Abscess.

Authors:  Abdurrahman Aycan; Ozgür Yusuf Aktas; Feyza Karagoz Guzey; Azmi Tufan; Cihan Isler; Nur Aycan; İsmail Gulsen; Harun Arslan
Journal:  Case Rep Infect Dis       Date:  2016-09-05

10.  Spinal epidural abscess in COVID-19 patients.

Authors:  G Talamonti; Davide Colistra; Francesco Crisà; Marco Cenzato; Pietro Giorgi; Giuseppe D'Aliberti
Journal:  J Neurol       Date:  2020-09-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.